DADC
PRAH

D.A. Davidson & Co’s PRA Health Sciences, Inc. PRAH Stock Holding History

D.A. Davidson & Co’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,365
Closed -$261K – 1187
2019
Q1 		$261K Sell
2,365
-333
-12% -$34.8K ﹤0.01% 943
2018
Q4 		$248K Buy
2,698
+146
+6% +$14.8K ﹤0.01% 890
2018
Q3 		$281K Sell
2,552
-610
-19% -$63.5K 0.01% 938
2018
Q2 		$295K Sell
3,162
-1,756
-36% -$151K 0.01% 883
2018
Q1 		$408K Buy
4,918
+20
+0.4% +$1.78K 0.01% 759
2017
Q4 		$446K Buy
4,898
+1,659
+51% +$138K 0.01% 704
2017
Q3 		$246K Sell
3,239
-56
-2% -$4.23K ﹤0.01% 928
2017
Q2 		$247K Sell
3,295
-71
-2% -$4.92K 0.01% 872
2017
Q1 		$219K Buy
+3,366
New +$198K 0.01% 899

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

D.A. Davidson & Co's PRAH Position: Q2 2019 in Review

D.A. Davidson & Co sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 2,365 shares — an estimated $261K sold.

D.A. Davidson & Co first reported a position in PRAH in Q1 2017 and held it in 9 quarters. The position peaked at $446K in Q4 2017. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • D.A. Davidson & Co reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • D.A. Davidson & Co sold 2,365 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $261K.
  • D.A. Davidson & Co first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 9 quarters.
  • D.A. Davidson & Co's PRA Health Sciences, Inc. position peaked at $446K in Q4 2017.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on D.A. Davidson & Co's 13F filing for Q2 2019, filed 13 Aug 2019.